Follow The Filings

INM InMed Pharmaceuticals

InMed Pharmaceuticals earnings company data as of 12:01 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —
FY2026 Q2 28 Sep EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by INM's executives, directors and 10% owners in the last 12 months, from their Form 4s

All INM insider trades
  • $1.4M bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
    Buy
    $1,435 1,087 shares at $1.32 +0.1% to stake
    Traded Oct 16–19 Filed Oct 20
    ↗
  2. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
    Buy
    $13K 9,569 shares at $1.33 +1% to stake
    Traded Oct 13–15 Filed Oct 15
    ↗
  3. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
    Buy
    $14K 10,903 shares at $1.33 +1.2% to stake
    Traded Oct 6–8 Filed Oct 8
    ↗
  4. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
    Buy
    $57K 42,920 shares at $1.33 +4.8% to stake
    Traded Oct 1–5 Filed Oct 5
    ↗
  5. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
    Buy
    $118K 91,101 shares at $1.30 +11% to stake
    Traded Sep 14–16 Filed Sep 16
    ↗
  6. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
    Buy
    $1,555 1,000 shares at $1.56 +0.1% to stake
    Traded Jul 15 Filed Jul 17
    ↗
  7. Vivo Opportunity, LLC 10% owner, +3 joint filers
    Buy
    $32K 20,546 shares at $1.55 +38% to stake
    Traded Jul 14–16 Filed Jul 16
    ↗
  8. Vivo Opportunity, LLC 10% owner, +3 joint filers
    Buy
    $10K 6,551 shares at $1.55 +9.8% to stake
    Traded Jun 30–Jul 2 Filed Jul 2
    ↗
  9. Vivo Opportunity, LLC 10% owner, +3 joint filers
    Buy
    $392K 249,227 shares at $1.57 New stake
    Traded May 20–Jun 8 Filed Jun 10
    ↗
  10. ADAR1 Capital Management, LLC 10% owner, +1 joint filer
    Buy
    $722K 468,551 shares at $1.54 +141% to stake
    Traded May 19 Filed May 21
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
424B3 Filing Doc
8-K 3.01,8.01,9.01 Filing Doc
10-K ANNUAL REPORT Filing Doc
SCHEDULE 13G — Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
SCHEDULE 13D — Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,3.03,8.01,9.01 Filing Doc
8-K 1.01,5.01,5.02,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q QUARTERLY REPORT Filing Doc
8-K 1.01,3.03,8.01,9.01 Filing Doc
424B5 PROSPECTUS SUPPLEMENT Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 3.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.05,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q QUARTERLY REPORT Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.